Nieuw LES: 1) #farmabedrijven nemen gepatenteerde kandidaat-geneesmiddelen met sterkere wortels in wetenschappelijk #onderzoek gemakkelijker op in klinische studies, 2) nog meer als ze zélf het onderzoek deden, dus *R* en *D* “onder één dak”. shorturl.at/tFHP3
ALT Titelpagina Leuvens Economisch Standpunt LES 2024/209
#Deadline approaching for the 17th #Workshop on the Organisation, Economics and Policy of Scientific Research, 18-19 April 2024, Turin! Submit your paper or extended abstract by 14 January 2024. More info: shorturl.at/xCIZ4#WOEPS#scisci
Call for papers for the 17th #Workshop on the Organisation, Economics and Policy of Scientific Research, 18-19 April 2024, Turin. Submit your paper or extended abstract by 14 January 2024. More info: shorturl.at/xCIZ4#WOEPS#scisci
Our new paper in the Journal of Technology Transfer on the role of in-house #science in #pharmaceutical firms. Takeaway: reducing investments in internal science may hurt productivity in drug development.
bit.ly/3l6ZXGb
Thanks to all who joined the inauguration of the 2022-2026 Research Chair in Science of Science and Innovation Policy at KU Leuven, sponsored by the FNR. Joint with Cindy Lopes Bento and Arvids Ziedonis, I’m looking forward to study, well, ourselves! ;-) bit.ly/3wm7GSU
New paper on a great #teamscience project where we 'competed' with 119 (!) other teams, investigating the (positive) link between #religiosity and #well-being. Main lesson: 'many analysts' approach much more insightful than 'comments from 2 reviewers'. :-) bit.ly/3Oh9IKC
And our reflection on how the measurement of complex constructs critically affects findings. E.g. health/medical well-being is *negatively* related to religiosity. bit.ly/3o8Rkc8
We are #hiring! The Department of Management, Strategy, and Innovation (MSI) of KU Leuven has 3 full-time academic positions (at various ranks) in the areas of Strategic Management, Entrepreneurship, and Managerial Economics. More info here: bit.ly/3RKZuoz